Physician profile
Lisa N Fields
NPI 1326597378
$679.51
in general payments reported to CMS, 2019-2025
14 companies · $52.40 in 2025
The $52.40 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $145 · 2022: $58.76 · 2023: $188 · 2024: $236 · 2025: $52.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $204.48 | 2021-2024 | |
| Novo Nordisk INC | $108.26 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $76.47 | 2023-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $69.37 | 2021-2025 | |
| Pfizer INC. | $55.11 | 2023-2025 | |
| Viiv Healthcare Company | $37.49 | 2023-2025 | Apretude |
| Organon LLC | $20.98 | 2021 | |
| Avita Medical Americas, LLC | $18.19 | 2023 | Recell |
| Irhythm Technologies, INC. | $18.15 | 2021 | |
| Averitas Pharma INC. | $16.14 | 2023 | Qutenza |
| Amgen INC. | $14.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.07 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $13.90 | 2022 | |
| Genentech USA, INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.